309 related articles for article (PubMed ID: 29435987)
41. The molecular characterization, expression pattern and alternative initiation of Megalobrama amblycephala Hif prolyl hydroxylase Phd1.
Chen N; Huang CX; Huang CH; He Y; Chen TS; Zhu DM; Liu H; Wang WM; Wang HL
Gene; 2018 Dec; 678():219-225. PubMed ID: 30086363
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.
Manresa MC; Taylor CT
Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):303-315. PubMed ID: 28462372
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways.
Ullah K; Rosendahl AH; Izzi V; Bergmann U; Pihlajaniemi T; Mäki JM; Myllyharju J
Sci Rep; 2017 Dec; 7(1):17220. PubMed ID: 29222481
[TBL] [Abstract][Full Text] [Related]
44. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation.
Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K
Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.
Webb JD; Coleman ML; Pugh CW
Cell Mol Life Sci; 2009 Nov; 66(22):3539-54. PubMed ID: 19756382
[TBL] [Abstract][Full Text] [Related]
46. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.
Nangaku M; Kojima I; Tanaka T; Ohse T; Kato H; Fujita T
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):129-39. PubMed ID: 18221080
[TBL] [Abstract][Full Text] [Related]
47. The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
Li A; Zhang Y; Wang Z; Dong H; Fu N; Han X
Chem Biol Interact; 2019 Apr; 303():40-49. PubMed ID: 30817904
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
Rabinowitz MH
J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
[TBL] [Abstract][Full Text] [Related]
49. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal.
Dallatu MK; Choi M; Oyekan AO
J Hypertens; 2013 Oct; 31(10):2043-9. PubMed ID: 23811999
[TBL] [Abstract][Full Text] [Related]
51. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
52. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
Giatromanolaki A; Koukourakis MI; Pezzella F; Turley H; Sivridis E; Bouros D; Bougioukas G; Harris AL; Gatter KC
Cancer Lett; 2008 Apr; 262(1):87-93. PubMed ID: 18187257
[TBL] [Abstract][Full Text] [Related]
53. Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O
Park H
Toxicol Res; 2008 Jun; 24(2):101-107. PubMed ID: 32038783
[TBL] [Abstract][Full Text] [Related]
54. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
[TBL] [Abstract][Full Text] [Related]
55. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells.
Ortmann B; Bensaddek D; Carvalhal S; Moser SC; Mudie S; Griffis ER; Swedlow JR; Lamond AI; Rocha S
J Cell Sci; 2016 Jan; 129(1):191-205. PubMed ID: 26644182
[TBL] [Abstract][Full Text] [Related]
56. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
57. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
[TBL] [Abstract][Full Text] [Related]
58. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
59. Prolyl hydroxylases and therapeutics.
Smith TG; Talbot NP
Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
Koivunen P; Kietzmann T
Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
